APO Research

APO RESEARCH · REPORT

Herbal Medicine

Herbal medicine--also called botanical medicine or phytomedicine refers to using a plant's seeds, berries, roots, leaves, bark, or flowers for medicinal purposes. Herbalism has a long tradition of use outside of conventional medicine. It is becoming more mainstream as improvements in analysis and quality control along with advances in clinical research show the value of herbal medicine in the treating and preventing disease.

Product & engineering

Understand the product.

Herbal medicine--also called botanical medicine or phytomedicine refers to using a plant's seeds, berries, roots, leaves, bark, or flowers for medicinal purposes. Herbalism has a long tradition of use outside of conventional medicine. It is becoming more mainstream as improvements in analysis and quality control along with advances in clinical research show the value of herbal medicine in the treating and preventing disease.

Traditional herbal medicines are naturally occurring, plant-derived substances with minimal or no industrial processing that have been used to treat illness within local or regional healing practices.

Selected research

Market Outlook & Growth Opportunities

Global Herbal Medicine Market Outlook and Growth Opportunities 2026

Market perspective

Herbal medicine--also called botanical medicine or phytomedicine refers to using a plant's seeds, berries, roots, leaves, bark, or flowers for medicinal purposes. Herbalism has a long tradition of use outside of conventional medicine. It is becoming more mainstream as improvements in analysis and quality control along with advances in clinical research show the value of herbal medicine in the treating and preventing disease.

Traditional herbal medicines are naturally occurring, plant-derived substances with minimal or no industrial processing that have been used to treat illness within local or regional healing practices.

Asia-Pacific is the largest region of Herbal Medicine, with a market share about 50%, followed by Europe and North America, etc. Tsumura, Schwabe, Yunnan Baiyao, Tongrentang and TASLY are the key manufacturers of industry, and top 10 players had less than 25% combined market share.

Read the full market overview

This report provides an overview of the global Herbal Medicine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Herbal Medicine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Herbal Medicine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Herbal Medicine market size, projected growth trends, production technologies, key applications, and end-use industries.

Herbal Medicine Segment by Company

Tsumura

Schwabe

Madaus

Weleda

Blackmores

Arkopharma

SIDO MUNCUL

Arizona Natural

Dabur

Herbal Africa

Nature’s Answer

Bio-Botanica

Potter’s

Zand

Nature Herbs

Imperial Ginseng

Yunnan Baiyao

Tongrentang

TASLY

Zhongxin

Kunming Pharma

Sanjiu

JZJT

Guangzhou Pharma

Taiji

Haiyao

Herbal Medicine Segment by Type

Detoxification Medicine

Antipyretic Medicine

Aigestant Medicine

Blood Circulation Medicine

Others

Herbal Medicine Segment by Application

Western Herbalism

Traditional Chinese Medicine

Others

Herbal Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Herbal Medicine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Herbal Medicine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Herbal Medicine significant trends, drivers, influence factors in global and regions.

6. To analyze Herbal Medicine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Herbal Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Herbal Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Herbal Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Herbal Medicine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Herbal Medicine industry.

Chapter 3: Detailed analysis of Herbal Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Herbal Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Herbal Medicine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Herbal Medicine Industry Trends Table 2. Herbal Medicine Industry Drivers Table 3. Herbal Medicine Industry Opportunities and Challenges Table 4. Herbal Medicine Industry Restraints Table 5. Global Herbal Medicine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Herbal Medicine Revenue Share by Company (2021-2026) Table 7. Global Herbal Medicine Sales Volume by Company (t) & (2021-2026) Table 8. Global Herbal Medicine Sales Volume Share by Company (2021-2026) Table 9. Global Herbal Medicine Average Price (USD/kg) of Company (2021-2026) Table 10. Global Herbal Medicine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Herbal Medicine Key Company Manufacturing Base & Headquarters Table 12. Global Herbal Medicine Company, Product Type & Application Table 13. Global Herbal Medicine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Herbal Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Detoxification Medicine Table 18. Significant Companies of Antipyretic Medicine Table 19. Significant Companies of Aigestant Medicine Table 20. Significant Companies of Blood Circulation Medicine Table 21. Significant Companies of Others Table 22. Global Herbal Medicine Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 23. Global Herbal Medicine Sales Volume by Type (2021-2026) & (t) Table 24. Global Herbal Medicine Sales Volume by Type (2027-2032) & (t) Table 25. Global Herbal Medicine Sales Volume Share by Type (2021-2026) Table 26. Global Herbal Medicine Sales Volume Share by Type (2027-2032) Table 27. Global Herbal Medicine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Herbal Medicine Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Herbal Medicine Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Herbal Medicine Sales Value Share by Type (2021-2026) Table 31. Global Herbal Medicine Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Western Herbalism Table 33. Significant Companies of Traditional Chinese Medicine Table 34. Significant Companies of Others Table 35. Global Herbal Medicine Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 36. Global Herbal Medicine Sales Volume by Application (2021-2026) & (t) Table 37. Global Herbal Medicine Sales Volume by Application (2027-2032) & (t) Table 38. Global Herbal Medicine Sales Volume Share by Application (2021-2026) Table 39. Global Herbal Medicine Sales Volume Share by Application (2027-2032) Table 40. Global Herbal Medicine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Herbal Medicine Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Herbal Medicine Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Herbal Medicine Sales Value Share by Application (2021-2026) Table 44. Global Herbal Medicine Sales Value Share by Application (2027-2032) Table 45. Global Herbal Medicine Sales by Region: 2021 VS 2025 VS 2032 (t) Table 46. Global Herbal Medicine Sales by Region (2021-2026) & (t) Table 47. Global Herbal Medicine Sales Market Share by Region (2021-2026) Table 48. Global Herbal Medicine Sales by Region (2027-2032) & (t) Table 49. Global Herbal Medicine Sales Market Share by Region (2027-2032) Table 50. Global Herbal Medicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Herbal Medicine Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Herbal Medicine Sales Value Share by Region (2021-2026) Table 53. Global Herbal Medicine Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Herbal Medicine Sales Value Share by Region (2027-2032) Table 55. Global Herbal Medicine Market Average Price (USD/kg) by Region (2021-2026) Table 56. Global Herbal Medicine Market Average Price (USD/kg) by Region (2027-2032) Table 57. Global Herbal Medicine Sales by Country: 2021 VS 2025 VS 2032 (t) Table 58. Global Herbal Medicine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Herbal Medicine Sales by Country (2021-2026) & (t) Table 60. Global Herbal Medicine Sales Market Share by Country (2021-2026) Table 61. Global Herbal Medicine Sales by Country (2027-2032) & (t) Table 62. Global Herbal Medicine Sales Market Share by Country (2027-2032) Table 63. Global Herbal Medicine Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Herbal Medicine Sales Value Market Share by Country (2021-2026) Table 65. Global Herbal Medicine Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Herbal Medicine Sales Value Market Share by Country (2027-2032) Table 67. Tsumura Company Information Table 68. Tsumura Business Overview Table 69. Tsumura Herbal Medicine Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 70. Tsumura Herbal Medicine Product Portfolio Table 71. Tsumura Recent Development Table 72. Schwabe Company Information Table 73. Schwabe Business Overview Table 74. Schwabe Herbal Medicine Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 75. Schwabe Herbal Medicine Product Portfolio Table 76. Schwabe Recent Development Table 77. Madaus Company Information Table 78. Madaus Business Overview Table 79. Madaus Herbal Medicine Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 80. Madaus Herbal Medicine Product Portfolio Table 81. Madaus Recent Development Table 82. Weleda Company Information Table 83. Weleda Business Overview Table 84. Weleda Herbal Medicine Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 85. Weleda Herbal Medicine Product Portfolio Table 86. Weleda Recent Development Table 87. Blackmores Company Information Table 88. Blackmores Business Overview Table 89. Blackmores Herbal Medicine Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 90. Blackmores Herbal Medicine Product Portfolio Table 91. Blackmores Recent Development Table 92. Arkopharma Company Information Table 93. Arkopharma Business Overview Table 94. Arkopharma Herbal Medicine Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 95. Arkopharma Herbal Medicine Product Portfolio Table 96. Arkopharma Recent Development Table 97. SIDO MUNCUL Company Information Table 98. SIDO MUNCUL Business Overview Table 99. SIDO MUNCUL Herbal Medicine Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 100. SIDO MUNCUL Herbal Medicine Product Portfolio Table 101. SIDO MUNCUL Recent Development Table 102. Arizona Natural Company Information Table 103. Arizona Natural Business Overview Table 104. Arizona Natural Herbal Medicine Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 105. Arizona Natural Herbal Medicine Product Portfolio Table 106. Arizona Natural Recent Development Table 107. Dabur Company Information Table 108. Dabur Business Overview Table 109. Dabur Herbal Medicine Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 110. Dabur Herbal Medicine Product Portfolio Table 111. Dabur Recent Development Table 112. Herbal Africa Company Information Table 113. Herbal Africa Business Overview Table 114. Herbal Africa Herbal Medicine Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 115. Herbal Africa Herbal Medicine Product Portfolio Table 116. Herbal Africa Recent Development Table 117. Nature’s Answer Company Information Table 118. Nature’s Answer Business Overview Table 119. Nature’s Answer Herbal Medicine Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 120. Nature’s Answer Herbal Medicine Product Portfolio Table 121. Nature’s Answer Recent Development Table 122. Bio-Botanica Company Information Table 123. Bio-Botanica Business Overview Table 124. Bio-Botanica Herbal Medicine Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 125. Bio-Botanica Herbal Medicine Product Portfolio Table 126. Bio-Botanica Recent Development Table 127. Potter’s Company Information Table 128. Potter’s Business Overview Table 129. Potter’s Herbal Medicine Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 130. Potter’s Herbal Medicine Product Portfolio Table 131. Potter’s Recent Development Table 132. Zand Company Information Table 133. Zand Business Overview Table 134. Zand Herbal Medicine Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 135. Zand Herbal Medicine Product Portfolio Table 136. Zand Recent Development Table 137. Nature Herbs Company Information Table 138. Nature Herbs Business Overview Table 139. Nature Herbs Herbal Medicine Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 140. Nature Herbs Herbal Medicine Product Portfolio Table 141. Nature Herbs Recent Development Table 142. Imperial Ginseng Company Information Table 143. Imperial Ginseng Business Overview Table 144. Imperial Ginseng Herbal Medicine Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 145. Imperial Ginseng Herbal Medicine Product Portfolio Table 146. Imperial Ginseng Recent Development Table 147. Yunnan Baiyao Company Information Table 148. Yunnan Baiyao Business Overview Table 149. Yunnan Baiyao Herbal Medicine Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 150. Yunnan Baiyao Herbal Medicine Product Portfolio Table 151. Yunnan Baiyao Recent Development Table 152. Tongrentang Company Information Table 153. Tongrentang Business Overview Table 154. Tongrentang Herbal Medicine Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 155. Tongrentang Herbal Medicine Product Portfolio Table 156. Tongrentang Recent Development Table 157. TASLY Company Information Table 158. TASLY Business Overview Table 159. TASLY Herbal Medicine Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 160. TASLY Herbal Medicine Product Portfolio Table 161. TASLY Recent Development Table 162. Zhongxin Company Information Table 163. Zhongxin Business Overview Table 164. Zhongxin Herbal Medicine Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 165. Zhongxin Herbal Medicine Product Portfolio Table 166. Zhongxin Recent Development Table 167. Kunming Pharma Company Information Table 168. Kunming Pharma Business Overview Table 169. Kunming Pharma Herbal Medicine Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 170. Kunming Pharma Herbal Medicine Product Portfolio Table 171. Kunming Pharma Recent Development Table 172. Sanjiu Company Information Table 173. Sanjiu Business Overview Table 174. Sanjiu Herbal Medicine Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 175. Sanjiu Herbal Medicine Product Portfolio Table 176. Sanjiu Recent Development Table 177. JZJT Company Information Table 178. JZJT Business Overview Table 179. JZJT Herbal Medicine Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 180. JZJT Herbal Medicine Product Portfolio Table 181. JZJT Recent Development Table 182. Guangzhou Pharma Company Information Table 183. Guangzhou Pharma Business Overview Table 184. Guangzhou Pharma Herbal Medicine Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 185. Guangzhou Pharma Herbal Medicine Product Portfolio Table 186. Guangzhou Pharma Recent Development Table 187. Taiji Company Information Table 188. Taiji Business Overview Table 189. Taiji Herbal Medicine Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 190. Taiji Herbal Medicine Product Portfolio Table 191. Taiji Recent Development Table 192. Haiyao Company Information Table 193. Haiyao Business Overview Table 194. Haiyao Herbal Medicine Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 195. Haiyao Herbal Medicine Product Portfolio Table 196. Haiyao Recent Development Table 197. Key Raw Materials Table 198. Raw Materials Key Suppliers Table 199. Herbal Medicine Distributors List Table 200. Herbal Medicine Customers List Table 201. Research Programs/Design for This Report Table 202. Authors List of This Report Table 203. Secondary Sources Table 204. Primary Sources List of Figures Figure 1. Herbal Medicine Product Image Figure 2. Global Herbal Medicine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Herbal Medicine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Herbal Medicine Sales (2021-2032) & (t) Figure 5. Global Herbal Medicine Sales Average Price (USD/kg) & (2021-2032) Figure 6. Global Herbal Medicine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Detoxification Medicine Image Figure 10. Antipyretic Medicine Image Figure 11. Aigestant Medicine Image Figure 12. Blood Circulation Medicine Image Figure 13. Others Image Figure 14. Global Herbal Medicine Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 15. Global Herbal Medicine Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Herbal Medicine Sales Volume Share by Type (2021-2032) Figure 17. Global Herbal Medicine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Herbal Medicine Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Herbal Medicine Sales Value Share by Type (2021-2032) Figure 20. Western Herbalism Image Figure 21. Traditional Chinese Medicine Image Figure 22. Others Image Figure 23. Global Herbal Medicine Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 24. Global Herbal Medicine Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Herbal Medicine Sales Volume Share by Application (2021-2032) Figure 26. Global Herbal Medicine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Herbal Medicine Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Herbal Medicine Sales Value Share by Application (2021-2032) Figure 29. Global Herbal Medicine Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 30. Global Herbal Medicine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Herbal Medicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Herbal Medicine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Herbal Medicine Sales Value (2021-2032) & (US$ Million) Figure 34. North America Herbal Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Herbal Medicine Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Herbal Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Herbal Medicine Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Herbal Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Herbal Medicine Sales Value (2021-2032) & (US$ Million) Figure 40. South America Herbal Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Herbal Medicine Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Herbal Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Herbal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Herbal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Herbal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Herbal Medicine Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Herbal Medicine Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Detoxification Medicine
  • Antipyretic Medicine
  • Aigestant Medicine
  • Blood Circulation Medicine
  • Others
Applications
  • Western Herbalism
  • Traditional Chinese Medicine
  • Others
Companies covered
  • Tsumura
  • Schwabe
  • Madaus
  • Weleda
  • Blackmores
  • Arkopharma
  • SIDO MUNCUL
  • Arizona Natural
  • Dabur
  • Herbal Africa
  • Nature’s Answer
  • Bio-Botanica
  • Potter’s
  • Zand
  • Nature Herbs
  • Imperial Ginseng
  • Yunnan Baiyao
  • Tongrentang
  • TASLY
  • Zhongxin
  • Kunming Pharma
  • Sanjiu
  • JZJT
  • Guangzhou Pharma
  • Taiji
  • Haiyao

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Herbal Medicine Sales Value (2021-2032)
  4. 1.2.2 Global Herbal Medicine Sales Volume (2021-2032)
  5. 1.2.3 Global Herbal Medicine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Herbal Medicine Market Dynamics
  1. 2.1 Herbal Medicine Industry Trends
  2. 2.2 Herbal Medicine Industry Drivers
  3. 2.3 Herbal Medicine Industry Opportunities and Challenges
  4. 2.4 Herbal Medicine Industry Restraints
3 Herbal Medicine Market by Company
  1. 3.1 Global Herbal Medicine Company Revenue Ranking in 2025
  2. 3.2 Global Herbal Medicine Revenue by Company (2021-2026)
  3. 3.3 Global Herbal Medicine Sales Volume by Company (2021-2026)
  4. 3.4 Global Herbal Medicine Average Price by Company (2021-2026)
  5. 3.5 Global Herbal Medicine Company Ranking (2024-2026)
  6. 3.6 Global Herbal Medicine Company Manufacturing Base and Headquarters
  7. 3.7 Global Herbal Medicine Company Product Type and Application
  8. 3.8 Global Herbal Medicine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Herbal Medicine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Herbal Medicine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Herbal Medicine Market by Type
  1. 4.1 Herbal Medicine Type Introduction
  2. 4.1.1 Detoxification Medicine
  3. 4.1.2 Antipyretic Medicine
  4. 4.1.3 Aigestant Medicine
  5. 4.1.4 Blood Circulation Medicine
  6. 4.1.5 Others
  7. 4.2 Global Herbal Medicine Sales Volume by Type
  8. 4.2.1 Global Herbal Medicine Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Herbal Medicine Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Herbal Medicine Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Herbal Medicine Sales Value by Type
  12. 4.3.1 Global Herbal Medicine Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Herbal Medicine Sales Value by Type (2021-2032)
  14. 4.3.3 Global Herbal Medicine Sales Value Share by Type (2021-2032)
5 Herbal Medicine Market by Application
  1. 5.1 Herbal Medicine Application Introduction
  2. 5.1.1 Western Herbalism
  3. 5.1.2 Traditional Chinese Medicine
  4. 5.1.3 Others
  5. 5.2 Global Herbal Medicine Sales Volume by Application
  6. 5.2.1 Global Herbal Medicine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Herbal Medicine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Herbal Medicine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Herbal Medicine Sales Value by Application
  10. 5.3.1 Global Herbal Medicine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Herbal Medicine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Herbal Medicine Sales Value Share by Application (2021-2032)
6 Herbal Medicine Regional Sales and Value Analysis
  1. 6.1 Global Herbal Medicine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Herbal Medicine Sales by Region (2021-2032)
  3. 6.2.1 Global Herbal Medicine Sales by Region: 2021-2026
  4. 6.2.2 Global Herbal Medicine Sales by Region (2027-2032)
  5. 6.3 Global Herbal Medicine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Herbal Medicine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Herbal Medicine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Herbal Medicine Sales Value by Region (2027-2032)
  9. 6.5 Global Herbal Medicine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Herbal Medicine Sales Value (2021-2032)
  12. 6.6.2 North America Herbal Medicine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Herbal Medicine Sales Value (2021-2032)
  15. 6.7.2 Europe Herbal Medicine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Herbal Medicine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Herbal Medicine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Herbal Medicine Sales Value (2021-2032)
  21. 6.9.2 South America Herbal Medicine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Herbal Medicine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Herbal Medicine Sales Value Share by Country, 2025 VS 2032
7 Herbal Medicine Country-level Sales and Value Analysis
  1. 7.1 Global Herbal Medicine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Herbal Medicine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Herbal Medicine Sales by Country (2021-2032)
  4. 7.3.1 Global Herbal Medicine Sales by Country (2021-2026)
  5. 7.3.2 Global Herbal Medicine Sales by Country (2027-2032)
  6. 7.4 Global Herbal Medicine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Herbal Medicine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Herbal Medicine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Herbal Medicine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Herbal Medicine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Herbal Medicine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Herbal Medicine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Herbal Medicine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Herbal Medicine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Herbal Medicine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Herbal Medicine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Herbal Medicine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Herbal Medicine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Herbal Medicine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Herbal Medicine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Herbal Medicine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Herbal Medicine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Herbal Medicine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Herbal Medicine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Herbal Medicine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Herbal Medicine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Herbal Medicine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Herbal Medicine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Herbal Medicine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Herbal Medicine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Herbal Medicine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Herbal Medicine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Herbal Medicine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Herbal Medicine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Herbal Medicine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Herbal Medicine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Herbal Medicine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Herbal Medicine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Herbal Medicine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Tsumura
  2. 8.1.1 Tsumura Company Information
  3. 8.1.2 Tsumura Business Overview
  4. 8.1.3 Tsumura Herbal Medicine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Tsumura Herbal Medicine Product Portfolio
  6. 8.1.5 Tsumura Recent Developments
  7. 8.2 Schwabe
  8. 8.2.1 Schwabe Company Information
  9. 8.2.2 Schwabe Business Overview
  10. 8.2.3 Schwabe Herbal Medicine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Schwabe Herbal Medicine Product Portfolio
  12. 8.2.5 Schwabe Recent Developments
  13. 8.3 Madaus
  14. 8.3.1 Madaus Company Information
  15. 8.3.2 Madaus Business Overview
  16. 8.3.3 Madaus Herbal Medicine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Madaus Herbal Medicine Product Portfolio
  18. 8.3.5 Madaus Recent Developments
  19. 8.4 Weleda
  20. 8.4.1 Weleda Company Information
  21. 8.4.2 Weleda Business Overview
  22. 8.4.3 Weleda Herbal Medicine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Weleda Herbal Medicine Product Portfolio
  24. 8.4.5 Weleda Recent Developments
  25. 8.5 Blackmores
  26. 8.5.1 Blackmores Company Information
  27. 8.5.2 Blackmores Business Overview
  28. 8.5.3 Blackmores Herbal Medicine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Blackmores Herbal Medicine Product Portfolio
  30. 8.5.5 Blackmores Recent Developments
  31. 8.6 Arkopharma
  32. 8.6.1 Arkopharma Company Information
  33. 8.6.2 Arkopharma Business Overview
  34. 8.6.3 Arkopharma Herbal Medicine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Arkopharma Herbal Medicine Product Portfolio
  36. 8.6.5 Arkopharma Recent Developments
  37. 8.7 SIDO MUNCUL
  38. 8.7.1 SIDO MUNCUL Company Information
  39. 8.7.2 SIDO MUNCUL Business Overview
  40. 8.7.3 SIDO MUNCUL Herbal Medicine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 SIDO MUNCUL Herbal Medicine Product Portfolio
  42. 8.7.5 SIDO MUNCUL Recent Developments
  43. 8.8 Arizona Natural
  44. 8.8.1 Arizona Natural Company Information
  45. 8.8.2 Arizona Natural Business Overview
  46. 8.8.3 Arizona Natural Herbal Medicine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Arizona Natural Herbal Medicine Product Portfolio
  48. 8.8.5 Arizona Natural Recent Developments
  49. 8.9 Dabur
  50. 8.9.1 Dabur Company Information
  51. 8.9.2 Dabur Business Overview
  52. 8.9.3 Dabur Herbal Medicine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Dabur Herbal Medicine Product Portfolio
  54. 8.9.5 Dabur Recent Developments
  55. 8.10 Herbal Africa
  56. 8.10.1 Herbal Africa Company Information
  57. 8.10.2 Herbal Africa Business Overview
  58. 8.10.3 Herbal Africa Herbal Medicine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Herbal Africa Herbal Medicine Product Portfolio
  60. 8.10.5 Herbal Africa Recent Developments
  61. 8.11 Nature’s Answer
  62. 8.11.1 Nature’s Answer Company Information
  63. 8.11.2 Nature’s Answer Business Overview
  64. 8.11.3 Nature’s Answer Herbal Medicine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Nature’s Answer Herbal Medicine Product Portfolio
  66. 8.11.5 Nature’s Answer Recent Developments
  67. 8.12 Bio-Botanica
  68. 8.12.1 Bio-Botanica Company Information
  69. 8.12.2 Bio-Botanica Business Overview
  70. 8.12.3 Bio-Botanica Herbal Medicine Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Bio-Botanica Herbal Medicine Product Portfolio
  72. 8.12.5 Bio-Botanica Recent Developments
  73. 8.13 Potter’s
  74. 8.13.1 Potter’s Company Information
  75. 8.13.2 Potter’s Business Overview
  76. 8.13.3 Potter’s Herbal Medicine Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Potter’s Herbal Medicine Product Portfolio
  78. 8.13.5 Potter’s Recent Developments
  79. 8.14 Zand
  80. 8.14.1 Zand Company Information
  81. 8.14.2 Zand Business Overview
  82. 8.14.3 Zand Herbal Medicine Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Zand Herbal Medicine Product Portfolio
  84. 8.14.5 Zand Recent Developments
  85. 8.15 Nature Herbs
  86. 8.15.1 Nature Herbs Company Information
  87. 8.15.2 Nature Herbs Business Overview
  88. 8.15.3 Nature Herbs Herbal Medicine Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Nature Herbs Herbal Medicine Product Portfolio
  90. 8.15.5 Nature Herbs Recent Developments
  91. 8.16 Imperial Ginseng
  92. 8.16.1 Imperial Ginseng Company Information
  93. 8.16.2 Imperial Ginseng Business Overview
  94. 8.16.3 Imperial Ginseng Herbal Medicine Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Imperial Ginseng Herbal Medicine Product Portfolio
  96. 8.16.5 Imperial Ginseng Recent Developments
  97. 8.17 Yunnan Baiyao
  98. 8.17.1 Yunnan Baiyao Company Information
  99. 8.17.2 Yunnan Baiyao Business Overview
  100. 8.17.3 Yunnan Baiyao Herbal Medicine Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Yunnan Baiyao Herbal Medicine Product Portfolio
  102. 8.17.5 Yunnan Baiyao Recent Developments
  103. 8.18 Tongrentang
  104. 8.18.1 Tongrentang Company Information
  105. 8.18.2 Tongrentang Business Overview
  106. 8.18.3 Tongrentang Herbal Medicine Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Tongrentang Herbal Medicine Product Portfolio
  108. 8.18.5 Tongrentang Recent Developments
  109. 8.19 TASLY
  110. 8.19.1 TASLY Company Information
  111. 8.19.2 TASLY Business Overview
  112. 8.19.3 TASLY Herbal Medicine Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 TASLY Herbal Medicine Product Portfolio
  114. 8.19.5 TASLY Recent Developments
  115. 8.20 Zhongxin
  116. 8.20.1 Zhongxin Company Information
  117. 8.20.2 Zhongxin Business Overview
  118. 8.20.3 Zhongxin Herbal Medicine Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Zhongxin Herbal Medicine Product Portfolio
  120. 8.20.5 Zhongxin Recent Developments
  121. 8.21 Kunming Pharma
  122. 8.21.1 Kunming Pharma Company Information
  123. 8.21.2 Kunming Pharma Business Overview
  124. 8.21.3 Kunming Pharma Herbal Medicine Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Kunming Pharma Herbal Medicine Product Portfolio
  126. 8.21.5 Kunming Pharma Recent Developments
  127. 8.22 Sanjiu
  128. 8.22.1 Sanjiu Company Information
  129. 8.22.2 Sanjiu Business Overview
  130. 8.22.3 Sanjiu Herbal Medicine Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 Sanjiu Herbal Medicine Product Portfolio
  132. 8.22.5 Sanjiu Recent Developments
  133. 8.23 JZJT
  134. 8.23.1 JZJT Company Information
  135. 8.23.2 JZJT Business Overview
  136. 8.23.3 JZJT Herbal Medicine Sales, Value and Gross Margin (2021-2026)
  137. 8.23.4 JZJT Herbal Medicine Product Portfolio
  138. 8.23.5 JZJT Recent Developments
  139. 8.24 Guangzhou Pharma
  140. 8.24.1 Guangzhou Pharma Company Information
  141. 8.24.2 Guangzhou Pharma Business Overview
  142. 8.24.3 Guangzhou Pharma Herbal Medicine Sales, Value and Gross Margin (2021-2026)
  143. 8.24.4 Guangzhou Pharma Herbal Medicine Product Portfolio
  144. 8.24.5 Guangzhou Pharma Recent Developments
  145. 8.25 Taiji
  146. 8.25.1 Taiji Company Information
  147. 8.25.2 Taiji Business Overview
  148. 8.25.3 Taiji Herbal Medicine Sales, Value and Gross Margin (2021-2026)
  149. 8.25.4 Taiji Herbal Medicine Product Portfolio
  150. 8.25.5 Taiji Recent Developments
  151. 8.26 Haiyao
  152. 8.26.1 Haiyao Company Information
  153. 8.26.2 Haiyao Business Overview
  154. 8.26.3 Haiyao Herbal Medicine Sales, Value and Gross Margin (2021-2026)
  155. 8.26.4 Haiyao Herbal Medicine Product Portfolio
  156. 8.26.5 Haiyao Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Herbal Medicine Value Chain Analysis
  2. 9.1.1 Herbal Medicine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Herbal Medicine Sales Mode & Process
  6. 9.2 Herbal Medicine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Herbal Medicine Distributors
  9. 9.2.3 Herbal Medicine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research